Table of contents


In this issue

p711 | doi:10.1038/nrc1206

Top

Research Highlights

Tumorigenesis: Environmental impact | PDF (110 KB)

p713 | doi:10.1038/nrc1194

Oncogenes: One-man band | PDF (85 KB)

p714 | doi:10.1038/nrc1195

Web Watch

Plant power | PDF (85 KB)

p714 | doi:10.1038/nrc1203

Epigenetics: The upper hand | PDF (70 KB)

p715 | doi:10.1038/nrc1201

Trial Watch

Tobacco and DNA damage | PDF (70 KB)

p715 | doi:10.1038/nrc1204

Tumour classification: Recognizing differences | PDF (1,088 KB)

p716 | doi:10.1038/nrc1197

Tumour suppressors: Cylindromatosis: cause and treatment | PDF (61 KB)

p716 | doi:10.1038/nrc1202

Drug resistance: Clinging on | PDF (1,047 KB)

p717 | doi:10.1038/nrc1196

Metastasis: That time of the month | PDF (98 KB)

p718 | doi:10.1038/nrc1198

Breast cancer: Recurrence | PDF (98 KB)

p718 | doi:10.1038/nrc1199

Tumorigenesis: High-level Hedgehog hazard | PDF (47 KB)

p719 | doi:10.1038/nrc1200

News in Brief

Metastasis | Tumorigenesis | Epigenetics | Antisense therapy | PDF (47 KB)

p719 | doi:10.1038/nrc1205

Top

Reviews

Targeting HIF-1 for cancer therapy

Gregg L. Semenza

p721 | doi:10.1038/nrc1187

Tobacco carcinogens, their biomarkers and tobacco-induced cancer

Stephen S. Hecht

p733 | doi:10.1038/nrc1190

Cannabinoids: potential anticancer agents

Manuel Guzmán

p745 | doi:10.1038/nrc1188

The role of Notch in tumorigenesis: oncogene or tumour suppressor?

Freddy Radtke & Kenneth Raj

p756 | doi:10.1038/nrc1186

Cancer chemoprevention with dietary phytochemicals

Young-Joon Surh

p768 | doi:10.1038/nrc1189

Top

Perspectives

Innovation

New tools for functional mammalian cancer genetics

Thijn R. Brummelkamp & René Bernards

p781 | doi:10.1038/nrc1191

Opinion

Proteomic analysis of cancer-cell mitochondria

Mukesh Verma, Jacob Kagan, David Sidransky & Sudhir Srivastava

p789 | doi:10.1038/nrc1192

Natureview: Reviews and comment from the nature publishing group

p796 | doi:10.1038/nrc1207

Correspondence

Correspondence: Proteomic alterations of cancer-cell mitochondria: driver or bystander?

Carsten Goessl

| doi:10.1038/nrc1192-c1

Author Reply: Reply to "Proteomic alterations of cancer-cell mitochondria: driver or bystander?"

Mukesh Verma, Jacob Kagan, David Sidransky & Sudhir Srivastava

| doi:10.1038/nrc1192-c2

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

naturejobs

Advertisement